C07F 9/3873
Containing nitrogen substituent
Official title: {containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)}
C07F9/3873 (Containing nitrogen substituent) appears on 275 US grants and 188 published applications in this corpus.
Search patents in C07F- Granted patents
- 275
- Published applications
- 188
- Assignees
- 171
- Inventors
- 585
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 7 | 0 |
| 1978 | 6 | 0 |
| 1979 | 3 | 0 |
| 1980 | 3 | 0 |
| 1981 | 5 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 5 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 6 | 0 |
| 1991 | 7 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 12 | 0 |
| 1995 | 12 | 0 |
| 1996 | 7 | 0 |
| 1997 | 4 | 0 |
| 1998 | 9 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 2 |
| 2002 | 1 | 9 |
| 2003 | 11 | 3 |
| 2004 | 5 | 12 |
| 2005 | 4 | 8 |
| 2006 | 10 | 11 |
| 2007 | 6 | 12 |
| 2008 | 10 | 10 |
| 2009 | 6 | 17 |
| 2010 | 9 | 10 |
| 2011 | 6 | 2 |
| 2012 | 3 | 7 |
| 2013 | 3 | 6 |
| 2014 | 12 | 12 |
| 2015 | 6 | 9 |
| 2016 | 6 | 8 |
| 2017 | 8 | 11 |
| 2018 | 9 | 10 |
| 2019 | 11 | 6 |
| 2020 | 7 | 3 |
| 2021 | 5 | 7 |
| 2022 | 3 | 6 |
| 2023 | 4 | 2 |
| 2024 | 2 | 2 |
| 2025 | 4 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Sequestering compositions and materials3 Mar 2026US 12,565,584 B2Alliance for Energy Innovation, LLC
- Marking precursor with squaric acid coupling12 Aug 2025US 12,383,636 B2Telix Pharmaceuticals Limited
- Silanol compositions and methods of use27 May 2025US 12,312,495 B23M Innovative Properties Company
- Bone targeted antimicrobial oxazolidinone related compounds, formulations thereof, and uses thereof29 Apr 2025US 12,285,489 B2
- Hole-transporting self-organized monolayer for perovskite solar cells21 Jan 2025US 12,207,546 B2Helmholtz-Zentrum Berlin FüR Materialien Und Energie GmbH
- Phospholipid compounds and formulations27 Aug 2026US 2026/0248830 A1AVVIO Medical, Inc.
- Labeling precursors with squaric acid coupling18 Sep 2025US 2025/0288702 A1Telix Pharmaceuticals Limited
- Amide-linked conjugate compounds and uses thereof21 Aug 2025US 2025/0263428 A2Simon Fraser University
- Materials and methods for suppressing and/or treating bone related diseases and symptoms28 Nov 2024US 2024/0390399 A1Indiana University Research and Technology Corporation
- Phospholipid compounds and formulations13 Jun 2024US 2024/0189333 A1Applaud Medical, Inc.
Most cited
By later US patents
- Substituted imidazolium compounds for treating disease97US 8,901,162 B1Antecip Bioventures II LLC · 2014
- Substituted imidazolium compounds for treating disease94US 8,835,650 B1Antecip Bioventures II LLC · 2014
- Pharmacologically active biphosphonates, process for the preparation thereof and pharmaceutical compositions therefrom91US 4,621,077 AIstituto Gentili S.p.A. · 1986
- Diphosphonate derivatives, pharmaceutical compositions and methods of use84US 4,927,814 ABoehringer Mannheim GmbH · 1990
- Substituted imidazolium compounds for treating disease82US 9,006,279 B1Antecip Bioventures II LLC · 2015